Revvity Inc (RVTY) News

Form 4 - Statement of changes in beneficial ownership of securities

Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England

New agreement to support newborn health adds sequencing lab services to the existing extraction services collaboration Revvity, Inc. (NYSE:...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay

Company expands infectious disease diagnostics portfolio with first of several assays validated for dried blood spots as sample material Revvity...

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Form PRE 14A - Other preliminary proxy statements

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Revvity Wins Permanent Injunction Enforcing Agreements with Cloud Software Group

Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to...

Revvity to Present at Upcoming Investor Conferences

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences in March 2025: 46th Annual Raymond James...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]